Your browser doesn't support javascript.
loading
Construction of copy number variation landscape and characterization of associated genes in a Bangladeshi cohort of neurodevelopmental disorders.
Akter, Hosneara; Rahman, Muhammad Mizanur; Sarker, Shaoli; Basiruzzaman, Mohammed; Islam, Md Mazharul; Rahaman, Md Atikur; Rahaman, Md Ashiquir; Eshaque, Tamannyat Binte; Dity, Nushrat Jahan; Sarker, Shouvik; Amin, Md Robed; Hossain, Mohammad Monir; Lopa, Maksuda; Jahan, Nargis; Hossain, Shafaat; Islam, Amirul; Mondol, Ashaduzzaman; Faruk, Md Omar; Saha, Narayan; Kundu, Gopen Kumar; Kanta, Shayla Imam; Kazal, Rezaul Karim; Fatema, Kanij; Rahman, Md Ashrafur; Hasan, Maruf; Hossain Mollah, Md Abid; Hosen, Md Ismail; Karuvantevida, Noushad; Begum, Ghausia; Zehra, Binte; Nassir, Nasna; Nabi, A H M Nurun; Uddin, K M Furkan; Uddin, Mohammed.
Affiliation
  • Akter H; Genetics and Genomic Medicine Centre, NeuroGen Healthcare, Dhaka, Bangladesh.
  • Rahman MM; Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, Bangladesh.
  • Sarker S; Department of Paediatric Neurology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
  • Basiruzzaman M; Department of Child Neurology, NeuroGen Healthcare, Dhaka, Bangladesh.
  • Islam MM; Department of Paediatric Neuroscience, Dhaka Shishu Hospital, Dhaka, Bangladesh.
  • Rahaman MA; Department of Child Neurology, NeuroGen Healthcare, Dhaka, Bangladesh.
  • Rahaman MA; Department of Neurology, National Institute of Neurosciences and Hospital, Dhaka, Bangladesh.
  • Eshaque TB; Department of Child Neurology, NeuroGen Healthcare, Dhaka, Bangladesh.
  • Dity NJ; Department of Neurology, National Institute of Neurosciences and Hospital, Dhaka, Bangladesh.
  • Sarker S; Genetics and Genomic Medicine Centre, NeuroGen Healthcare, Dhaka, Bangladesh.
  • Amin MR; Centre for Precision Therapeutics, NeuroGen Healthcare, Dhaka, Bangladesh.
  • Hossain MM; Genetics and Genomic Medicine Centre, NeuroGen Healthcare, Dhaka, Bangladesh.
  • Lopa M; Genetics and Genomic Medicine Centre, NeuroGen Healthcare, Dhaka, Bangladesh.
  • Jahan N; Institute of Plant Genetics, Department of Plant Biotechnology, Leibniz University Hannover, Hanover, Germany.
  • Hossain S; Department of Medicine, Dhaka Medical College, Dhaka, Bangladesh.
  • Islam A; Department of Paediatric Neurology, National Institute of Neuroscience and Hospital, Dhaka, Bangladesh.
  • Mondol A; Centre for Precision Therapeutics, NeuroGen Healthcare, Dhaka, Bangladesh.
  • Faruk MO; Centre for Precision Therapeutics, NeuroGen Healthcare, Dhaka, Bangladesh.
  • Saha N; Department of Biology and Biochemistry, University of Houston, Houston, TX, United States.
  • Kundu GK; Genetics and Genomic Medicine Centre, NeuroGen Healthcare, Dhaka, Bangladesh.
  • Kanta SI; Cellular Intelligence Lab, GenomeArc Inc, Toronto, ON, Canada.
  • Kazal RK; Centre for Precision Therapeutics, NeuroGen Healthcare, Dhaka, Bangladesh.
  • Fatema K; Centre for Precision Therapeutics, NeuroGen Healthcare, Dhaka, Bangladesh.
  • Rahman MA; Department of Paediatric Neurology, National Institute of Neuroscience and Hospital, Dhaka, Bangladesh.
  • Hasan M; Department of Child Neurology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
  • Hossain Mollah MA; Department of Paediatric Neuroscience, Dhaka Shishu Hospital, Dhaka, Bangladesh.
  • Hosen MI; Department of Obstetrics and Gynaecology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
  • Karuvantevida N; Department of Paediatric Neurology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
  • Begum G; Department of Pharmaceutical Sciences, Wilkes University, Pennsylvania, PA, United States.
  • Zehra B; Department of Biomedical Engineering, Military Institute of Science and Technology, Dhaka, Bangladesh.
  • Nassir N; Department of Paediatrics, BIRDEM General Hospital, Dhaka, Bangladesh.
  • Nabi AHMN; Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, Bangladesh.
  • Uddin KMF; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
  • Uddin M; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Front Genet ; 14: 955631, 2023.
Article in En | MEDLINE | ID: mdl-36959829
Introduction: Copy number variations (CNVs) play a critical role in the pathogenesis of neurodevelopmental disorders (NDD) among children. In this study, we aim to identify clinically relevant CNVs, genes and their phenotypic characteristics in an ethnically underrepresented homogenous population of Bangladesh. Methods: We have conducted chromosomal microarray analysis (CMA) for 212 NDD patients with male to female ratio of 2.2:1.0 to identify rare CNVs. To identify candidate genes within the rare CNVs, gene constraint metrics [i.e., "Critical-Exon Genes (CEGs)"] were applied to the population data. Autism Diagnostic Observation Schedule-Second Edition (ADOS-2) was followed in a subset of 95 NDD patients to assess the severity of autism and all statistical tests were performed using the R package. Results: Of all the samples assayed, 12.26% (26/212) and 57.08% (121/212) patients carried pathogenic and variant of uncertain significance (VOUS) CNVs, respectively. While 2.83% (6/212) patients' pathogenic CNVs were found to be located in the subtelomeric regions. Further burden test identified females are significant carriers of pathogenic CNVs compared to males (OR = 4.2; p = 0.0007). We have observed an increased number of Loss of heterozygosity (LOH) within cases with 23.85% (26/109) consanguineous parents. Our analyses on imprinting genes show, 36 LOH variants disrupting 69 unique imprinted genes and classified these variants as VOUS. ADOS-2 subset shows severe social communication deficit (p = 0.014) and overall ASD symptoms severity (p = 0.026) among the patients carrying duplication CNV compared to the CNV negative group. Candidate gene analysis identified 153 unique CEGs in pathogenic CNVs and 31 in VOUS. Of the unique genes, 18 genes were found to be in smaller (<1 MB) focal CNVs in our NDD cohort and we identified PSMC3 gene as a strong candidate gene for Autism Spectrum Disorder (ASD). Moreover, we hypothesized that KMT2B gene duplication might be associated with intellectual disability. Conclusion: Our results show the utility of CMA for precise genetic diagnosis and its integration into the diagnosis, therapy and management of NDD patients.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Genet Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Genet Year: 2023 Document type: Article Affiliation country: Country of publication: